 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Phase III Randomized Study of Radiotherapy With
Versus Without Temozolomide in Patients With Symptomatic or Progressive
Low-Grade Gliomas
ECOG E3F05 (MBMC
Contact: Chris Joyce 314-996-5536) Click
For Consent
***
***Available
through CTSU
Brain (Glioblastoma) Cancer Trials in St. Louis, MO
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|